allarity.com (ALLR) Forward Price-to-Revenue Multiple

Public company logo of Allarity Therapeutics, Inc. (ALLR)

The forward P/S dynamics on the GURU.Markets service demonstrate how the market has priced in R&D expenses and liquidity for Allarity Therapeutics (ALLR) as the DRP AI platform achieves its first successes. The value of 40.10 reflects this current balance of supply and demand. The technology automates therapy selection, replacing manual data analysis, while the proprietary tool predicts drug efficacy via RNA for personalized cancer treatment.

ALLR Allarity Therapeutics Inc.: Market Cap to Future Revenue Ratio in the range 07/25/2022 - 11/17/2026

Summary analytical data breakdowns for Allarity Therapeutics Inc. (ALLR)

- market price and analyst price targets:
Initial company analysis:ALLR (allarity.com)
Product sample of Allarity Therapeutics, Inc.

Allarity Therapeutics maintains an ultra-compact workforce relying on external contractors to minimize fixed costs, rendering the financial model extremely sensitive to revenue dynamics. The projected price-to-sales ratio determines the fundamental margin of safety, measuring the recovery speed of commercial indicators inclusive of subsidies, where a sharp increase in this metric signals a risk of asset overvaluation relative to actual earnings.